Insider Shareholders with Direct Ownership of Acura Pharmaceuticals, Inc (ACUR)
This section provides a comprehensive overview of the insiders with direct ownership of Acura Pharmaceuticals, Inc (ACUR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ACURA PHARMACEUTICALS, INC Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Abuse Deterrent Pharma, Llc
> 10% Shareholder |
42,984,375 | 0 | 42,984,375 $0 | 1 |
Jun 09, 2021
Added 50.0%
|
Bruce F Wesson
Director |
225,622 | 0 | 829,548 $0 | 4 |
Jan 02, 2024
Added 4.33%
|
Robert B Jones
President & CEO |
217,333 | 0 | 643,555 $0 | 4 |
Nov 20, 2023
Added 5.85%
|
William G Skelly
Director |
238,122 | 0 | 575,989 $0 | 4 |
Jan 02, 2024
Added 7.99%
|
Peter A Clemens
Senior VP & CFO |
218,667 | 34,614 | 545,430 $0 | 7 |
Nov 20, 2023
Added 6.83%
|
George K Ross
Director |
238,122 | 0 | 495,503 $0 | 4 |
Jan 02, 2024
Added 9.17%
|
Albert W Brzeczko
Officer |
160,667 | 0 | 486,001 $0 | 4 |
Nov 20, 2023
Added 7.6%
|
James F Emigh
VP, Corporate Development |
44,667 | 14,952 | 474,042 $0 | 4 |
Feb 24, 2021
Reduced 1.57%
|
Immanuel Thangaraj
Director |
238,122 | 0 | 447,647 $0 | 4 |
Jan 02, 2024
Added 10.05%
|
Robert A Seiser
VP, Treasurer & Controller |
129,333 | 18,236 | 438,254 $0 | 7 |
Nov 20, 2023
Added 8.36%
|